Continuing Medical Education Questions: February 2021

Area of Science:

• Gastroenterology
• Hepatology
• Diagnostic Medicine

Background:

• Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease.
• Identifying patients with NASH at high risk for adverse outcomes is crucial for timely intervention.
• Current diagnostic methods for NASH risk stratification have limitations.

Purpose of the Study:

• To provide expert panel recommendations on utilizing noninvasive tests in clinical gastroenterology.
• To identify patients with non-alcoholic steatohepatitis (NASH) at high risk for adverse outcomes.
• To enhance the clinical management of NASH.

Main Methods:

• Systematic review of existing literature on noninvasive tests for NASH.
• Consensus-building among a panel of gastroenterology and hepatology experts.
• Development of evidence-based recommendations for clinical practice.

Main Results:

• Noninvasive tests, including blood biomarkers and imaging techniques, can effectively identify high-risk NASH patients.
• Specific algorithms and criteria are proposed for integrating these tests into routine gastroenterology workflows.
• Recommendations address the selection, interpretation, and follow-up of patients based on test results.

Conclusions:

• Noninvasive tests offer a valuable tool for risk stratification in non-alcoholic steatohepatitis (NASH) within gastroenterology practices.
• These recommendations aim to improve patient outcomes by facilitating early identification and management of high-risk individuals.
• Widespread adoption of these guidelines can optimize the clinical care of patients with NASH.